Q2 2025 earnings release furnished; no specific figures provided in filing text

TANDEM DIABETES CARE INC

2025-Q2 EPS reported -$2.74 revenue$475,100,000

Press release dated June 30, 2025, furnished as Exhibit 99.1, but content not included in the provided filing text.
Item 2.02 reports financial results for quarter ended June 30, 2025, but actual numbers are unavailable for summarization.
Investors should refer to the full press release for specific financial data.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.